Manuscripts

Search by keyword, year, or author name.

Showing 1590 manuscripts.

Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay.

Ada Cachafeiro, Gayle G. Sherman, A. Sohn, C. Beck-Sague, Susan A. Fiscus, Ph.D. Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. Journal of Clinical Microbiology. 2008 Dec 10; 47(2):459-62. PMID: 19073872; PMCID: PMC2643698.

Year

2008

Journal

Journal of Clinical Microbiology

Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy

Thomas C. Greenough, M.D., Coleen K. Cunningham, M.D., Petronella Muresan, M.S., Margaret McManus, B.S., Deborah Persaud, M.D., Terence Fenton, Ed.D., Piers Barker, M.D., Aditya Gaur, M.D., Dennis Panicali, Ph.D., John L. Sullivan, M.D., Katherine Luzuriaga, M.D. Safety and Immunogenicity of Recombinant Poxvirus HIV-1 Vaccines in Young Adults on Highly Active Antiretroviral Therapy. Vaccine. 2008 Oct 20; 26(52):6883-93. PMID: 18940219; PMCID: PMC2845914.

Year

2008

Journal

Vaccine

Study

P1059

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s

Francesca J. Torriani, M.D., Lauren Komarow, M.S., Robert A. Parker, Sc.D., Bruno R. Cotter, M.D., Judith Silverstein Currier, M.D., M.Sc., Michael P. Dube, M.D., Carl J. Fichtenbaum, M.D., Mariana Gerschenson, Ph.D., Carol K. Mitchell, Robert L. Murphy, M.D., Kathleen E. Squires, M.D., James H. Stein, M.D. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS clinical trials group) study 5152s. Journal of the American College of Cardiology. 2008 Aug 12; 52(7):569-76. PMCID: PMC2603599.

Year

2008

Journal

Journal of the American College of Cardiology

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

Pablo Tebas, M.D., W. Keith Henry, M.D., Roy Matining, M.S., Deborah Weng-Cherng, M.S., John L. Schmitz, Ph.D., Hernan Valdez, M.D., Nasreen Jahed, M.P.H., Laurie S. Myers, M.S., M.T. (A.S.C.P.), William G. Powderly, M.D., David Katzenstein, M.D. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. Public Library of Science One. 2008 Apr 23; 3(4):1-6. PMCID: PMC2292263.

Year

2008

Journal

Public Library of Science One

Class-sparing regimens for initial treatment of HIV-1 infection

Sharon A. Riddler, M.D., M.P.H., Richard H. Haubrich, M.D., Greg DiRienzo, Ph.D., Lynne Peeples, M.S., William G. Powderly, M.D., Karin L. Klingman, M.D., Kevin W. Garren, Ph.D., Tania George, Pharm.D., James F. Rooney, M.D., Barbara Brizz, M.H.S.Ed., B.S.N., Umesh Gangharam Lalloo, M.D., F.R.C.P., Robert L. Murphy, M.D., Susan Swindells, M.B.B.S., Diane V. Havlir, M.D., John W. Mellors, M.D. Class-sparing regimens for initial treatment of HIV-1 infection. New England Journal of Medicine. 2008 May 15; 358(20):2095-106.

Year

2008

Journal

New England Journal of Medicine

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

Samir K. Gupta, M.D., Susan L Rosenkranz, Ph.D., Yoninah S. Cramer, M.S., Susan L. Koletar, M.D., Lynda Anne Szczech, M.D., M.S.C.E., Valerianna Amorosa, M.D., Stephen D Hall, Ph.D. The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. AIDS. 2008 Oct 01; 22(15):1919-27. PMCID: PMC2675161.

Year

2008

Journal

AIDS

Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts

Heather Ribaudo, Ph.D., Daniel R. Kuritzkes, M.D., Christina M. Lalama, M.S., Jeffrey T. Schouten, M.D.,J.D., Bruce R. Schackman, Ph.D., Edward P. Acosta, Pharm.D., Roy (Trip) Gulick, M.D., M.P.H. Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts. Journal of Infectious Diseases. 2008 Apr 01; 197(7):1006-10.

Year

2008

Journal

Journal of Infectious Diseases

Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury

Constantin Yiannoutsos, Ph.D., Christos T. Nakas, Bradford A. Navia, M.D. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury. Neuroimage. 2008 Mar 01; 10(1):248-55.

Year

2008

Journal

Neuroimage

Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093

Heather D. Watts, M.D., Jeong-Gun Park, Ph.D., Susan Ellen Cohn, M.D., M.P.H., Song Yu, M.S., Jane Hitti, M.D., M.P.H., Alice M. Stek, M.D., Pamela A. Clax, D.P.M., Laila Muderspach, M.D., Juan J.L. Lertora, M.D., Ph.D. Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093. Contraception. 2008 Feb 01; 77(2):84-90. PMCID: PMC2424313.

Year

2008

Journal

Contraception

Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV infected-mothers on antiretroviral therapy

Grace McComsey, M.D., Minhee Kang, M.S., Ph.D., Allison Ross, M.D., Dirk Lebrecht, Elizabeth Livingston, M.D., Ann J. Melvin, M.D., M.P.H., Jane Hitti, M.D., M.P.H., Susan Ellen Cohn, M.D., M.P.H., Ulrich A. Walker. Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV infected-mothers on antiretroviral therapy. HIV Clinical Trials. 2008 Mar 01; 9(2):126-36.

Year

2008

Journal

HIV Clinical Trials